Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Replimune Group | REPL | Nov 1, 2024 | 11.90 | +1.19 |
ReposiTrak | TRAK | Nov 1, 2024 | 18.99 | -1.35 |
Republic Bancorp A | RBCAA | Nov 1, 2024 | 67.49 | -0.01 |
Republic Services | RSG | Nov 1, 2024 | 198.58 | +0.29 |
Research Frontiers | REFR | Nov 1, 2024 | 2.15 | -2.27 |
Research Solutions | RSSS | Nov 1, 2024 | 2.63 | -0.19 |
Reservoir Media | RSVR | Nov 1, 2024 | 8.25 | -0.96 |
ReShape Lifesciences | RSLS | Nov 1, 2024 | 5.88 | +4.07 |
Resideo Technologies | REZI | Nov 1, 2024 | 19.98 | +1.58 |
ResMed | RMD | Nov 1, 2024 | 244.28 | +0.75 |
Resources Connection | RGP | Nov 1, 2024 | 7.96 | -1.12 |
Restaurant Brands International | QSR | Nov 1, 2024 | 69.98 | +0.62 |
Retail Bull 3X Direxion | RETL | Nov 1, 2024 | 8.55 | +1.91 |
Retail ETF Market Vectors | RTH | Nov 1, 2024 | 218.23 | +1.98 |
Retail Opportunity Investments | ROIC | Nov 1, 2024 | 15.59 | +0.58 |
ReTo Eco-Solutions | RETO | Nov 1, 2024 | 1.13 | 0.00 |
Retractable Technologies | RVP | Nov 1, 2024 | 0.71 | -1.59 |
REV Group | REVG | Nov 1, 2024 | 26.35 | -0.57 |
Revance Therapeutics | RVNC | Nov 1, 2024 | 5.80 | -1.69 |
Revelation Biosciences | REVB | Nov 1, 2024 | 0.82 | -3.52 |
Revenueshares Largecap | RWL | Nov 1, 2024 | 97.31 | +0.21 |
Revenueshares Midcap | RWK | Nov 1, 2024 | 115.42 | +0.19 |
Revenueshares Smallcap | RWJ | Nov 1, 2024 | 44.34 | +0.32 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 1, 2024 | 49.33 | -1.13 |
Reviva Pharmaceuticals | RVPH | Nov 1, 2024 | 0.98 | -12.72 |
Revolution Medicines | RVMD | Nov 1, 2024 | 55.09 | +2.97 |
Revolve Group A | RVLV | Nov 1, 2024 | 24.96 | +0.56 |
Revvity | RVTY | Nov 1, 2024 | 121.04 | +2.07 |
REX American Resources | REX | Nov 1, 2024 | 44.30 | -0.96 |
Rexford Industrial Realty | REXR | Nov 1, 2024 | 42.55 | -0.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.